Erasca, Inc. (ERAS)
17.45
-0.58
(-3.22%)
USD |
NASDAQ |
Aug 31, 14:32
Erasca Cash from Operations (Annual) : -95.46M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -95.46M |
| December 31, 2024 | -109.42M |
| December 31, 2023 | -101.22M |
| December 31, 2022 | -103.26M |
| Date | Value |
|---|---|
| December 31, 2021 | -79.60M |
| December 31, 2020 | -32.69M |
| December 31, 2019 | -10.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Revolution Medicines, Inc. | -897.74M |
| Tango Therapeutics, Inc. | -138.89M |
| Cogent Biosciences, Inc. | -264.44M |
| Apogee Therapeutics, Inc. | -227.45M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |